<DOC>
	<DOCNO>NCT00395941</DOCNO>
	<brief_summary>Acitretin , give combiantion pioglitazone might achieve good and/or rapid control moderate severe chronic plaque type psoriasis .</brief_summary>
	<brief_title>Efficacy Safety Acitretin Plus Pioglitazone Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Patients chronic plaque type psoriasis body surface area involvement &gt; 20 % Patients either sex Females complete family tubectomized postmenopausal i.e . menstrual bleeding least 1 year Age range 1865 year Females child bear potential H/O hypersensitivity acitretin Impaired hepatic function ( serum bilirubin , AST , ALT alkaline phosphatase &gt; 1.5 time upper limit normal ) Impaired renal function ( serum creatinine &gt; 1.5mg % male &gt; 1.4 mg % female ) Hyperlipidemia BMI &gt; 30 kg /m2 H/O excessive alcohol use Diabetes mellitus Congestive heart failure Ischemic heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>